RxDoctor Payments Data

Zoe Rodriguez

Pediatric Infectious Diseases · San Juan, PRNPI 1265487490

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $776 of the $931 with a category attached, or 83.4%. 5 manufacturers reported payments, led by Merck at 59.9% of the total. Reporting peaked in 2019 at $456 and has fallen 56.1% since, to $200 in 2025.

$931in general payments, 2019–2025

Across 18 payments — averaging $51.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$557
  • Gilead$289
  • Viiv Healthcare Company$60
  • Theratechnologies Inc.$12
  • Johnson & Johnson$12
$801,673in research payments, 2019–2025

Across 243 payments — averaging $3299.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$802K

What the payments were for

  • Travel & lodging$15417%
  • Food & beverage$77683%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric infectious diseases providers in Puerto Ricoto place this figure against a meaningful peer group, so we don't.

Other pediatric infectious diseases in San Juan

Where these figures come from

Is this you, or does something look wrong? →